Furthermore, GLP-1 RAs have shown anti-fibrotic effects in non-cancer contexts, such as liver and kidney fibrosis, raising the hypothesis that they might remodel desmoplastic stroma and improve therapeutic penetration in solid tumours. Here, GLP1R is linked to cancer.